Urol. praxi. 2021;22(4):211-214 | DOI: 10.36290/uro.2021.012

Transitional cell carcinoma of the prostate

MUDr. Přemysl Grubský ml.1, MUDr. Abdulbaset Hafuda1, MUDr. Vojtěch Mezera, Ph.D.2, MUDr. Ivan Kolombo, FEBU3, MUDr. Jiří Vorlíček4
1 Urologické oddělení, Pardubická nemocnice, Pardubice
2 Geriatrické centrum, Pardubická nemocnice, Pardubice
3 Urologická klinika, Fakultní nemocnice Královské Vinohrady, Praha
4 Patologicko-anatomické oddělení, Oblastní nemocnice Mladá Boleslav

In this article, we present two cases of patients diagnosed with transitional cell carcinoma (TCC) of the prostate. Both patients initially received surgical treatment. One of them, however, required reoperation and the other one required adjuvant chemotherapy. This rare type of tumor can appear as a solitary component or as a mixed tumor of the prostate. For succesful treatment of the TCC of the prostate, an early and exact diagnosis with histopathology is necessary, as the treatment differs greatly from that of conventional adenocarcinoma of the prostate.

Keywords: transitional cell carcinoma of the prostate, prostate cancer, oncological treatment, urological oncology, case report.

Received: March 10, 2021; Revised: March 10, 2021; Accepted: March 10, 2021; Prepublished online: March 10, 2021; Published: November 24, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Grubský P, Hafuda A, Mezera V, Kolombo I, Vorlíček J. Transitional cell carcinoma of the prostate. Urol. praxi. 2021;22(4):211-214. doi: 10.36290/uro.2021.012.
Download citation

References

  1. Kurfürstová D, Král M. Adenokarcinom prostaty a hodnocení stupně jeho diferenciace: změny v hodnocení Gleasonova skóre od jeho vzniku po současnost a jeho význam pro praxi patologa a urologa. Urol. praxi 2013; 14(4): 157-159.
  2. Kawaciuk I. Urologie. Praha: Galén, 2009: 531 S. ISBN 9788072626267.
  3. Nicolaisen GS, Williams RD. Primary transitional cell carcinoma of prostate. Urology 1984; 24: 544-549. Go to original source... Go to PubMed...
  4. Oliai BR, Kahane H, Epstein JI. A clinicopathologic analysis of urothelial carcinomas diagnosed on prostate needle biopsy. Am J Surg Pathol 2001; 25: 794-801. Go to original source... Go to PubMed...
  5. Gangadharan V, Prakash V, Eswari V, et al. Primary urothelial carcinoma of prostate: a rare case report. Int J Med res Health Sci. 2014; 3(1): 212-215. Go to original source...
  6. Shen SS, Lerner SP, Muezzinoglu B, et al. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance. Hum Pathol Jun 2006; 37(6): 726-734. Go to original source... Go to PubMed...
  7. Mao W, Xie J, Wu Y, et al. Cost-effectiveness analysis of two kinds of bladder cancer urinary diversion: Studer versus Bricker. Transl Androl Urol. 2020; 9(3): 1113-1119. doi: 10.21037/tau.2020.03.46. PMID: 32676395; PMCID: PMC7354334. Go to original source... Go to PubMed...
  8. Walsh DL, Chang SS. Dilemmas in the treatment of urothelial cancers of the prostate. Urol Oncol 2009; 27: 352-357. Go to original source... Go to PubMed...
  9. Zhou J, et al. Primary urothelial carcinoma of the prostate: A rare case report. Medicine 2019; 98(3): e14155. doi: 10.1097/MD.0000000000014155. Go to original source... Go to PubMed...




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.